Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Patch for Oxaliplatin-Induced Neuropathy
NCT05866653Phase 2Unknown
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Mar 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lidocaine 10% oropharyngeal spray (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoint: Visual Analogue Scale Pain Score at 6 weeks. Status: unknown.
02
Drugs
lidocaine 10% oropharyngeal spray
Beyond the preview
Go deeper on NCT05866653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05866653.